Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBPNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.22NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.22NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.36NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.36NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.37NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.37NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AD.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-16197.2US
AD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AD.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-16933China
XBB.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.26.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.26.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.26.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.10.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.10.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.10.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAY.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAY.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAY.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CY.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CY.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBTNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBTNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBTNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.33NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used